Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Fabrice Chouraqui Steps Down as CEO of Pharming

Pharmaceutical Executive Daily: Fabrice Chouraqui Steps Down as CEO of Pharming

Published 1 month, 2 weeks ago
Description
New U.S. guidance carves out tariff exemptions for specialty pharmaceuticals, Pharming's Fabrice Chouraqui steps down as CEO amid a board rift, and a dealmaking roundup covers Hengrui Pharma's licensing agreement with Novo Nordisk and AstraZeneca's investment in Summit Therapeutics.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us